280 related articles for article (PubMed ID: 9813160)
21. 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration.
Waza M; Adachi H; Katsuno M; Minamiyama M; Sang C; Tanaka F; Inukai A; Doyu M; Sobue G
Nat Med; 2005 Oct; 11(10):1088-95. PubMed ID: 16155577
[TBL] [Abstract][Full Text] [Related]
22. [Transcriptional regulation and subcellular localization of mutant androgen receptor in spinal and bulbar muscular atrophy].
Miwa S; Li M; Sobue G
Nihon Rinsho; 1999 Apr; 57(4):869-73. PubMed ID: 10222781
[TBL] [Abstract][Full Text] [Related]
23. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract.
Wellington CL; Ellerby LM; Hackam AS; Margolis RL; Trifiro MA; Singaraja R; McCutcheon K; Salvesen GS; Propp SS; Bromm M; Rowland KJ; Zhang T; Rasper D; Roy S; Thornberry N; Pinsky L; Kakizuka A; Ross CA; Nicholson DW; Bredesen DE; Hayden MR
J Biol Chem; 1998 Apr; 273(15):9158-67. PubMed ID: 9535906
[TBL] [Abstract][Full Text] [Related]
24. Role of the androgen receptor CAG repeat polymorphism in prostate cancer, and spinal and bulbar muscular atrophy.
Kumar R; Atamna H; Zakharov MN; Bhasin S; Khan SH; Jasuja R
Life Sci; 2011 Mar; 88(13-14):565-71. PubMed ID: 21284948
[TBL] [Abstract][Full Text] [Related]
25. Degradation properties of polyglutamine-expanded human androgen receptor in transfected cells.
Cullen DA; Leigh PN; Gallo JM
Neurosci Lett; 2004 Mar; 357(3):175-8. PubMed ID: 15003278
[TBL] [Abstract][Full Text] [Related]
26. Molecular pathophysiology and disease-modifying therapies for spinal and bulbar muscular atrophy.
Katsuno M; Banno H; Suzuki K; Adachi H; Tanaka F; Sobue G
Arch Neurol; 2012 Apr; 69(4):436-40. PubMed ID: 22158719
[TBL] [Abstract][Full Text] [Related]
27. Nonneural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy.
Li M; Nakagomi Y; Kobayashi Y; Merry DE; Tanaka F; Doyu M; Mitsuma T; Hashizume Y; Fischbeck KH; Sobue G
Am J Pathol; 1998 Sep; 153(3):695-701. PubMed ID: 9736019
[TBL] [Abstract][Full Text] [Related]
28. Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients.
Atsuta N; Watanabe H; Ito M; Banno H; Suzuki K; Katsuno M; Tanaka F; Tamakoshi A; Sobue G
Brain; 2006 Jun; 129(Pt 6):1446-55. PubMed ID: 16621916
[TBL] [Abstract][Full Text] [Related]
29. Alleviating neurodegeneration by an anticancer agent: an Hsp90 inhibitor (17-AAG).
Waza M; Adachi H; Katsuno M; Minamiyama M; Tanaka F; Sobue G
Ann N Y Acad Sci; 2006 Nov; 1086():21-34. PubMed ID: 17185503
[TBL] [Abstract][Full Text] [Related]
30. Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives.
Katsuno M; Adachi H; Tanaka F; Sobue G
J Mol Med (Berl); 2004 May; 82(5):298-307. PubMed ID: 15133611
[TBL] [Abstract][Full Text] [Related]
31. [Paradigm shift in clinical trials for neurodegenerative diseases].
Katsuno M; Banno H; Suzuki K; Takeuchi Y; Sobue G
Brain Nerve; 2007 Apr; 59(4):367-74. PubMed ID: 17447523
[TBL] [Abstract][Full Text] [Related]
32. Polyglutamine-expanded androgen receptor truncation fragments activate a Bax-dependent apoptotic cascade mediated by DP5/Hrk.
Young JE; Garden GA; Martinez RA; Tanaka F; Sandoval CM; Smith AC; Sopher BL; Lin A; Fischbeck KH; Ellerby LM; Morrison RS; Taylor JP; La Spada AR
J Neurosci; 2009 Feb; 29(7):1987-97. PubMed ID: 19228953
[TBL] [Abstract][Full Text] [Related]
33. Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice.
Bingham PM; Scott MO; Wang S; McPhaul MJ; Wilson EM; Garbern JY; Merry DE; Fischbeck KH
Nat Genet; 1995 Feb; 9(2):191-6. PubMed ID: 7719348
[TBL] [Abstract][Full Text] [Related]
34. Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy.
Takeuchi Y; Katsuno M; Banno H; Suzuki K; Kawashima M; Atsuta N; Ito M; Watanabe H; Tanaka F; Sobue G
Muscle Nerve; 2008 Aug; 38(2):964-71. PubMed ID: 18642379
[TBL] [Abstract][Full Text] [Related]
35. Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy.
Montie HL; Cho MS; Holder L; Liu Y; Tsvetkov AS; Finkbeiner S; Merry DE
Hum Mol Genet; 2009 Jun; 18(11):1937-50. PubMed ID: 19279159
[TBL] [Abstract][Full Text] [Related]
36. Proteasome-mediated proteolysis of the polyglutamine-expanded androgen receptor is a late event in spinal and bulbar muscular atrophy (SBMA) pathogenesis.
Heine EM; Berger TR; Pluciennik A; Orr CR; Zboray L; Merry DE
J Biol Chem; 2015 May; 290(20):12572-84. PubMed ID: 25795778
[TBL] [Abstract][Full Text] [Related]
37. Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy.
Bailey CK; Andriola IF; Kampinga HH; Merry DE
Hum Mol Genet; 2002 Mar; 11(5):515-23. PubMed ID: 11875046
[TBL] [Abstract][Full Text] [Related]
38. Consequences of poly-glutamine repeat length for the conformation and folding of the androgen receptor amino-terminal domain.
Davies P; Watt K; Kelly SM; Clark C; Price NC; McEwan IJ
J Mol Endocrinol; 2008 Nov; 41(5):301-14. PubMed ID: 18762554
[TBL] [Abstract][Full Text] [Related]
39. [Clinical manifestations and molecular genetics of spinal bulbar muscular atrophy: report of 5 cases].
Li XH; Zhuang JJ; Xie QY; Li AP; Liang XL; Feng YQ; Fang YY; Li JR; Liang YX
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1611-5. PubMed ID: 17803850
[TBL] [Abstract][Full Text] [Related]
40. Androgen receptor function in motor neuron survival and degeneration.
Cary GA; La Spada AR
Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):479-94, viii. PubMed ID: 18625411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
